ERBC (European Research Biology Center)
Guillaume Leleu is the Head of Human Resources at the European Research Biology Center since October 2022, emphasizing the importance of fostering equitable relationships between company management and employees for mutual growth. Prior to this role, Guillaume served as the Human Resources Manager at AFPI Centre Val de Loire et Trajectoire Industrie from February 2019 to October 2022. Previous experience includes roles as Project Manager and Consultant at ACTIFORCES, Project Manager in HR and Training in technical and industrial sectors at CONCEPT PARTENAIRE ENTREPRISES, and Career and Skills Manager at OGF. Early career included recruitment responsibilities at Unilever. Educational credentials encompass a Master 2 in Human Resource Management from the Conservatoire National des Arts et Métiers and a DESS in Work Psychology from Université Paris V, along with a Maîtrise in Work Psychology from Université Paris-Sorbonne.
ERBC (European Research Biology Center)
Stemming from the merger of two reference CROs in pharmacology and toxicology (CERB and RTC), European Research Biology Center (ERBC) is a European leader in non-clinical studies. It offers to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity. Based in Baugy (France) and Roma (Italy), ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, also benefiting from a world class academic and private network. Every year, study reports from our two Centers are successfully used in support of market authorization and new product approval submissions around the world, including the European (EMA, ECHA), US (FDA and EPA) and Japanese (MHLW and MAFF) regulatory authorities. Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international pharmaceutical and chemical companies. ERBC is deeply engaged in animal ethics and welfare. ERBC supports the Basel Declaration, respects the 3Rs concept and continually improves its tools and procedures to maximize the balance between the benefit for health and the animal well-being.